April 29, 2013
A New Jersey federal judge on Monday tossed several proposed racketeering class actions against Merck & Co. Inc. alleging the drugmaker interfered with health plan contracts by bribing participants with discounts that unlawfully made prescription plans pay higher prices for name-brand drugs, saying plaintiffs failed to plead the necessary facts.